Regular treatment with long acting beta agonists versus daily regular treatment with short acting beta agonists in adults and children with stable asthma
- 22 July 2002
- journal article
- research article
- Published by Wiley in Cochrane Database of Systematic Reviews
- Vol. 2002 (3) , CD003901
- https://doi.org/10.1002/14651858.cd003901
Abstract
No abstract availableKeywords
This publication has 155 references indexed in Scilit:
- The rising prevalence of asthma in young Melbourne adults is associated with improvement in treatmentAnnals of Allergy, Asthma & Immunology, 2001
- Comparison of powder and aerosol formulations of salmeterol in the treatment of asthmaAnnals of Allergy, Asthma & Immunology, 2000
- Comparative study of extended release albuterol sulfate and long-acting inhaled salmeterol xinafoate in the treatment of nocturnal asthmaAnnals of Allergy, Asthma & Immunology, 1999
- A six-month, placebo-controlled comparison of the safety and efficacy of salmeterol or beclomethasone for persistent asthmaAnnals of Allergy, Asthma & Immunology, 1999
- Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthmaAnnals of Allergy, Asthma & Immunology, 1999
- Prevention of exercise-induced bronchospasm in pediatric asthma patients: a comparison of salmeterol powder with albuterolAnnals of Allergy, Asthma & Immunology, 1999
- Assessing the quality of reports of randomized clinical trials: Is blinding necessary?Controlled Clinical Trials, 1996
- Clinical pharmacology of long-acting β-receptor agonistsLife Sciences, 1993
- Formoterol, a new long-acting selective β-adrenergic receptor agonist: Double-blind comparison with salbutamol and placebo in children with asthmaJournal of Allergy and Clinical Immunology, 1989
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986